CONTRIBUTION OF ATRIAL FIBRILLATION TO FORMATION OF CARDIORENAL CORRELATION IN HYPERTENSIVE PATIENTS


Cite item

Full Text

Abstract

Aim. The aim of the study was to evaluate the contribution of atrial fibrillation into development of chronic renal disease in patients with hypertension. Materials and methods. Eighty patients divided into 3 groups were examined. Group 1 included patients with sinus cardiac rhythm ( n = 30), group 2 - patients with persisting form of atrial fibrillation ( n = 30), and group 3 - patients with constant one ( n = 20). Results. Presence of atrial fibrillation was revealed to contribute to development of chronic renal disease. Decrease in glomerular filtration rate progresses when a patient is moving (by the stages of natural atrial fibrillation course) and correlates with patient’s age, left atrium size and cardiac output fraction. Conclusions. Patients with atrial fibrillation should be considered as patients with a threat of development of chronic renal disease.

About the authors

Yu I Lebedeva

Пермский государственный медицинский университет им. академика Е.А. Вагнера

Email: Julial.87@mail.ru
аспирант кафедры госпитальной терапии

References

  1. Диагностика и лечение фибрилляции предсердий: рекомендации РКО, ВНОА и АССХ 2012, available at: http://www.scardio.ru/ content/Guidelines/Rekomendations_fibrillyacia_predserdii_2012.pdf
  2. Кобалава Ж.Д., Виллевальде С.В., Ефремцева М.А. Основы кардиоренальной медицины. М.: ГЭОТАР-Медиа 2014; 256.
  3. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Российские рекомендации. Российский кардиологический журнал 2014; 8 (112): 7-37.
  4. Состояние заместительной терапии больных с хронической почечной недостаточностью в РФ в 1998-2009 гг. Российское диализное общество. Нефрология и диализ 2011; 13 (3): 150-264.
  5. Функциональное состояние почек и прогнозирование сердечно-сосудистого риска: национальные клинические рекомендации: сборник. Под ред. Р.Г. Оганова. 3-е изд. М.: Силицея-Полиграф 2010; 558-584.
  6. Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderi-si M., Grobbee D.E., Jaarsma T., Kirchhof P., Kjeld-sen S.E., Laurent S., Manolis A.J., Nilsson P.M., Ruilope L.M. ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34 (28): 2159-2219.
  7. Watanabe H., Watanabe T., Sasaki S. et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009; 158 (4): 629-636.

Copyright (c) 2016 Lebedeva Y.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies